Inhibition of autoimmune encephalomyelitis by a tetracycline

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases

Liblau, R., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,111

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006

MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES

González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958

Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis

Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T. P., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 935

Glutamate excitotoxicity in a model of multiple sclerosis

Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744

Matrix metalloproteinases and diseases of the CNS

Yong, V. W., Forsyth, P. A., Bell, R. B., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 635

Central Nervous System Injury and Neuroprotection

Bonifacio, S. L., Gonzalez, F. F., & Ferriero, D. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0134-0.10061-7 · Cited by 16

Targeting inflammation and gut microbiota with antibacterial therapy: implications for central nervous system health

Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis

Shi, Y., Chen, Y., Pan, Y., Chen, G., Xiao, Z., Chen, X., Wang, M., & Liang, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112703 · Cited by 14

Immunological mechanisms in multiple sclerosis

Irani, D. N. (2005) · Clinical and Applied Immunology Reviews · doi:10.1016/j.cair.2005.06.001 · Cited by 14

Future neuroprotective strategies

Sättler, M. B., & Bähr, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.016 · Cited by 14

Emerging therapies in multiple sclerosis

Farrell, R. A., Heaney, D. C., & Giovannoni, G. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.797 · Cited by 14

Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives

Latronico, T., & Liuzzi, G. M. (2017) · Metalloproteinases In Medicine · doi:10.2147/mnm.s88655 · Cited by 13

Minocycline Protects PC12 Cells Against Cadmium-Induced Neurotoxicity by Modulating Apoptosis

Shayan, M., Mehri, S., Razavi, B. M., & Hosseinzadeh, H. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03305-4 · Cited by 14

Polymer: Bioceramic composites optimization by tetracycline addition

Pataro, A. L., Oliveira, M. F., Teixeira, K. I. R., Turchetti-Maia, R. M. M., Lopes, M. T. P., Wykrota, F. H. L., Sinisterra, R. D., & Cortés, M. E. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.038 · Cited by 13

Why minocycline can cause systemic lupus – a hypothesis and suggestions for therapeutic interventions based on it

Steensel, M. A. M. V. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.040 · Cited by 13

Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges

Chauhan, P., Kakkar, A. K., Singh, H., & Gautam, C. S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1838276 · Cited by 12

Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review

Tsai, Y., & Tsai, T. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20947296 · Cited by 12

Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future

Soares, N. L., & Vieira, H. L. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03456-1 · Cited by 14

Tetracycline Derivatives as Anti-inflammatory Agents and Potential Agents in Stroke Treatment

Koıstınaho, J., Yrjänheikki, J., Kauppinen, T. M., & Koistinaho, M. (2004) · Springer eBooks · doi:10.1007/978-3-662-05426-0_6 · Cited by 12

Cytotoxicity models of Huntington’s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies

Calabrese, E. J., Bhatia, T. N., Calabrese, V., Dhawan, G., Giordano, J., Hanekamp, Y. N., Kapoor, R., Kozumbo, W. J., & Leak, R. K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104371 · Cited by 12

Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice

Herrmann, I., Kellert, M., Spreer, A., Gerber, J., Eiffert, H., Prinz, M., & Nau, R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl446 · Cited by 12

Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer

Himmel, L. E., Lustberg, M. B., DeVries, A. C., Poi, M. J., Chen, C., & Kulp, S. K. (2016) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2016.08.001 · Cited by 11

Intracerebroventricular administration of lupus serum induces microglia activation and leukocyte adhesion in the cerebromicrovasculature of mice

Wang, X., Li, Y., Wang, Y., Feng, Q., Yang, P., & Qin, L. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576994 · Cited by 11

Minocycline as a Neuroprotective Agent in Arsenic-Induced Neurotoxicity in PC12 Cells

Shayan, M., Mehri, S., Razavi, B. M., & Hosseinzadeh, H. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03376-3 · Cited by 11

Effects of second generation tetracyclines on penicillin-epilepsy-induced hippocampal neuronal loss and motor incoordination in rats

Yılmaz, İ., Adıgüzel, E., Akdoğan, I., Kaya, E., & Hatip‐Al‐Khatib, I. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.027 · Cited by 11

Minocycline reduces experimental muscle hyperalgesia induced by repeated nerve growth factor injections in humans: A placebo‐controlled double‐blind drug‐crossover study

Dunn, J. S., Nagi, S. S., & Mahns, D. A. (2020) · European Journal of Pain · doi:10.1002/ejp.1558 · Cited by 10

The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications

Khawar, M. M., Ijaz, S., Goyal, P., Kandambige, D., Sharifa, M., Maslamani, A. N. J., Kutabi, S. A., Saleh, I., Albshir, M. M., Almadhoun, M. K. I. K., et al. (2023) · Cureus · doi:10.7759/cureus.48655 · Cited by 11

Influence of antibacterial drugs on the immune system

Labro, M. T. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7408-x_23 · Cited by 10

[Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine].

Gámez, J. (2008) · PubMed · Cited by 10

Matrix Metalloproteinases in Inflammatory Dermatoses

Czerwińśka, J., & Owczarczyk-Saczonek, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110319 · Cited by 9

Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitis

Makar, T. K., Nimmagadda, V. K. C., Patibandla, G. K., Le, T., Judge, S. I. V., Trisler, D. N., & Bever, C. T. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.005 · Cited by 9

Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation

Bhattacharjee, A., Purohit, P., & Roy, P. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.917867 · Cited by 9

Matrix Metalloproteinases, Synaptic Injury, and Multiple Sclerosis

Szklarczyk, A., & Conant, K. E. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00130 · Cited by 9

Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder

Erickson, C. A., Shaffer, R. C., Will, M., Schmitt, L., Horn, P. S., Hirst, K., Pedapati, E. V., Ober, N., Tumuluru, R. V., Handen, B. L., et al. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06132-1 · Cited by 9

The Neuroprotective Effect of Inflammation: Implications for the Therapy of Multiple Sclerosis

Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H., & Wekerle, H. (2006) · Springer eBooks · doi:10.1007/3-540-27626-2_3 · Cited by 8

Administration of minocycline ameliorates damage in a renal ischemia/reperfusion injury model

Xia, D., Shen, K., Zhong, W., & Pan, H. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i1.15101 · Cited by 8

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis

Lim, E. T., & Giovannoni, G. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.3.379 · Cited by 7

MULTIPLE SCLEROSIS IS ASSOCIATED WITH ALTERED QUANTITATIVE AND QUALITATIVE COMPOSITION OF INTESTINAL MICROBIOTA

Abdurasulova, I. N., Тарасова, Е. А., Ермоленко, Е. И., Eliseev, A. V., Matsulevich, A. V., Бисага, Г. Н., Skulyabin, D. I., Suvorov, A. N., & Клименко, В. М. (2015) · Medical academic journal · doi:10.17816/maj15355-67 · Cited by 7

Texture Analysis of MR Images of Minocycline Treated MS Patients

Zhang, Y., Zhu, H., Ferrari, R. J., Wei, X., Eliasziw, M., Metz, L. M., & Mitchell, J. R. (2003) · Lecture notes in computer science · doi:10.1007/978-3-540-39899-8_96 · Cited by 7

Probiotics in Health and Immunity: A First Step toward Understanding the Importance of Microbiota System in Translational Medicine

Isacco, C. G., Ballini, A., Vito, D. D., Inchingolo, A. M., Cantore, S., Paduanelli, G., Nguyen, K. C. D., Inchingolo, A. D., Dipalma, G., & Inchingolo, F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88601 · Cited by 7

Minocycline may attenuate postherpetic neuralgia

Zhang, Q., Peng, L., & Zhang, D. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.04.028 · Cited by 6

Minocycline Directly Enhances the Self-Renewal of Adult Neural Precursor Cells

Kuroda, A., Fuchigami, T., Fuke, S., Koyama, N., Ikenaka, K., & Hitoshi, S. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2422-6 · Cited by 6

Effect of chemically modified tetracycline-8 (CMT-8) on hematology, blood chemistry, cytokines and peripheral blood lymphocyte subsets of healthy dogs

Sainz, Á., García‐Sancho, M., Rodríguez‐Franco, F., Andrés, M. I. S., Rodríguez, C., Lucas, J. J. D., Andrés, M. D. S., Agulla, B., & Villaescusa, A. (2021) · Research in Veterinary Science · doi:10.1016/j.rvsc.2021.02.022 · Cited by 6

Advancement of therapies for neuroprotection in multiple sclerosis

Lo, A. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1355 · Cited by 6

Inflammation as a target of minocycline: special interest in the regulation of inflammasome signaling

Kauppinen, A., Salminen, A., & Kaarniranta, K. (2013) · Inflammasome · doi:10.2478/infl-2013-0002 · Cited by 5

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment

Raghib, M. F., & Bernitsas, E. (2023) · Biomedicines · doi:10.3390/biomedicines11113069 · Cited by 5

Tactile Learning within the Early Phase of Experimental Autoimmune Encephalomyelitis in Mice

Ayoobi, F., Fatemi, I., Roohbakhsh, A., & Shamsizadeh, A. (2013) · Neurophysiology · doi:10.1007/s11062-013-9373-6 · Cited by 5

Emerging therapies for MS

Waubant, E. L. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)90481-6 · Cited by 5

Evolving Therapies For Multiple Sclerosis

Korniychuk, E., Dempster, J. M., O’Connor, E. M., Alexander, J. S., Kelley, R. E., Kenner, M., Menon, U., Misra, V., Hoque, R., Gonzalez‐Toledo, E., et al. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79025-6 · Cited by 5

Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline

Department of Physiology, P. R. C., Maneshian, M., Nasirinezhad, F., Department of Physiology, P. R. C., Mohammadi, F., Intracellular Recording Lab, N. R. C., Behzadi, M., Intracellular Recording Lab, N. R. C., Asadi-Shekaari, M., Intracellular Recording Lab, N. R. C., et al. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.12.2.1980.1 · Cited by 4

Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial

Melink, Z., Lustberg, M. B., Schnell, P., Mezzanotte-Sharpe, J., & Orchard, T. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07457-w · Cited by 4

“Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases

Airola, C., Severino, A., Spinelli, I., Gasbarrini, A., Cammarota, G., Ianiro, G., & Ponziani, F. R. (2024) · Antibiotics · doi:10.3390/antibiotics13121176 · Cited by 6

Lung Transplantation for Sarcoidosis

Judson, M. A. (2005) · Lung biology in health and disease · doi:10.1201/b13773-35 · Cited by 4

Changes in the Qualitative and Quantitative Composition of the Intestinal Microflora in Rats in Experimental Allergic Encephalomyelitis

Abdurasulova, I. N., Тарасова, Е. А., Matsulevich, A. V., Eliseev, A. V., Ермоленко, Е. И., Suvorov, A. N., & Клименко, В. М. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0401-7 · Cited by 4

C10 Influence of antibacterial drugs on the immune system

Labro, M. T. (2011) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0136-8_25 · Cited by 4

Use of Tetracyclines for Bone Metastases

Seidlitz, E. P., Saikali, Z., & Singh, G. (2005) · Humana Press eBooks · doi:10.1385/1-59259-892-7:293 · Cited by 4

Emerging disease modifying therapies for multiple sclerosis

Waubant, E. L. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.1.145 · Cited by 4

The prospects for neuroprotection in MS.

Hohlfeld, R. (2003) · PubMed · Cited by 4

Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection

Saha, P., Saha, R., Chaudhuri, R. D., Sarkar, R., Sarkar, M., Koley, H., & Chawla‐Sarkar, M. (2024) · Viruses · doi:10.3390/v16081317 · Cited by 3

Can tetracyclines ensure help in Multiple Sclerosis immunotherapy?

Costa, P. V. D. C., Thomé, R., & Rapôso, C. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202101.010 · Cited by 3

Minocycline Attenuates Kidney Injury in a Rat Model Of Streptozotocin-Induced Diabetic Nephropathy

Yuan, H., Zhao, D., & Zhang, B. (2016) · International Conference on Biomedical and Biological Engineering (BBE) · doi:10.2991/bbe-16.2016.41 · Cited by 3

Study on Serum Cholinesterase as Marker of Chronic Liver Disease

Aboughazala, L. M. (2020) · Al-Azhar University Journal of Virus Researches and Studies · doi:10.21608/aujv.2020.106729 · Cited by 2

A Novel Concept of Treatment in MS: Targeting Both Oligodendrocyte Death and Inflammatory Processes by Inhibiting Poly(Adp-Ribose) Polymerase

Illés, Z., Lassmann, H., & Gallyas, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7953-6_15 · Cited by 2

Doxycycline in autoimmune central nervous system disorders in children: an in vitro study

Anlar, B., Şenbil, N., & Güven, A. (2007) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2007.2550 · Cited by 2

Remyelination in Multiple Sclerosis

Stangel, M., Pul, R., Skripuletz, T., Trebst, C., Voß, E. V., & Gudi, V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00009-5 · Cited by 3

Doxycycline and Minocycline Drugs as a Treatment Proposal for Inhibition of ARDS and Inflammatory Cytokines of SARS-CoV-2

Mostafa, M. A. (2020) · Al-Azhar University Journal of Virus Researches and Studies · doi:10.21608/aujv.2020.106725 · Cited by 2

Mechanism of Therapy for Sarcoidosis

Petrache, I., & Möller, D. R. (2005) · Lung biology in health and disease · doi:10.1201/b13773-32 · Cited by 2

Simple extraction method requiring no cleanup procedure for the detection of minocycline residues in porcine muscle and milk using triple quadrupole liquid chromatography-tandem mass spectrometry

Park, J., Jeong, D., Zhang, D., Kim, S., Cho, S., Cho, S., Yi, H., Shim, J., Kim, J.-S., El‐Aty, A. M. A., et al. (2016) · Applied Biological Chemistry · doi:10.1007/s13765-016-0158-7 · Cited by 2

An open-label, evaluator-blinded study

Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A. M., Mihăilescu, A., & Sadeh, M. (2007) · Cited by 2

Prebiotics and Probiotics

Karley, D., Nayak, K. K., & Kolla, V. (2024) · CRC Press eBooks · doi:10.1201/9781003160663-17 · Cited by 1

Enterococcus faecium L-3 Ameliorates the Severity of Experimental Allergic Encephalomyelitis in Rats by Influencing Gut Microbiota, Enterocytes, and Immune Functions

Abdurasulova, I. N., Matsulevich, A. V., Grefner, N. M., Трофимов, А. Н., Kudryavtsev, I. V., & Ermolenko, E. I. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025050059 · Cited by 1

Early Phase Trials of Minocycline in Amyotrophic Lateral Sclerosis

Gordon, P. H., Choi, J. D. W., Moore, D. H., & Miller, R. G. (2006) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232105000078 · Cited by 1

Proteases in CNS Infection and Inflammation

Kieseier, B., & Bernal, F. (2005) · Springer eBooks · doi:10.1007/0-387-23101-3_5 · Cited by 1

Commentary I

Birnbaum, G., Leist, T. P., & LUBLIN, F. D. (2007) · Neurology · doi:10.1212/01.wnl.0000275226.67269.a3 · Cited by 1

Pharmacology of Inflammation

Espejo, C., & Martinꝉ, R. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn066 · Cited by 1

Multiple Sklerose: potenzielle Therapieansätze und Update laufender Studien

Wiendl, H., Lehmann, H. C., Hohlfeld, R., Hartung, H., & Kieseier, B. C. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1665-4 · Cited by 1

Doxycycline and Minocycline Drugs as a Treatment Proposal for Inhibition of ARDS and Inflammatory Cytokine Mediators Caused by COVID19Preprint

Mostafa, M. (2020) · doi:10.21467/preprints.43 · Cited by 1

Lessons from the Past and Future Approaches for Immunologic Therapies in Multiple Sclerosis

Wiendl, H., Melzer, N., Kleinschnitz, C., & Meuth, S. G. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00020-6

Avaliação biológica de compósitos de polímeros biodegradáveis em uma matriz de biocerâmica com adição de tetraciclina

Pataro, A. L. (2005) · Americanae (AECID Library)

Inmunomodulación por agentes antimicrobianos en modelos experimentales de inmunocompromiso

Hernández, A., & Angeles, M. R. (2011) · Institutional Repository of the University of Granada (University of Granada)

Repair and Neuroprotective Strategies in Multiple Sclerosis

Dangond, F. (2005) · Humana Press eBooks · doi:10.1385/1-59259-855-2:193

Effects of Current Medical Therapies on Reparative and Neuroprotective Functions in Multiple Sclerosis

Antel, J. P., & Miron, V. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_9

Tetracykliners antiinflammatoriska egenskaper: Nya möjligheter för ett gammalt läkemedel

Rawley, V. (2012)

Altersbedingte Makuladegeneration: die Rolle von Licht bei der Entstehung degenerativer Veränderungen im menschlichen RPE und möglicher Zell-Schutz durch Minocyclin The Role of Light in the Developement of RPE Degeneration in AMD and Potential Cytoprotection of Minocycline

Thiele, S., Hirneiß, C., Neubauer, A. S., ULBIG, M. W., Kampik, A., & München, L.-M.-U. (2010)

Minocycline in Cerebral Ischemia and Excitotoxicity

Koıstınaho, J., & Koistinaho, M. (2006) · Springer eBooks · doi:10.1007/978-0-387-30383-3_14

Neuroprotection in multiple sclerosis

Nath, A., & Calabresi, P. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.049

Minocycline did not prevent the neurotoxic effects of amyloid β on intrinsic electrophysiological properties of hippocampal CA1 pyramidal neurons in a rat model of Alzheimer's disease

Daryani, S., Farzaei, A., Hosseinmardi, N., Bahrami, F., & Janahmadi, M. (2016)

Neue, experimentelle und zukünftige Therapieansätze

Aktaş, O., Wandinger, K., & Zipp, F. (2006) · Elsevier eBooks · doi:10.1016/b978-343722081-4.50022-8

Testing and Mechanisms of Neuroprotective Agents for Cerebral Ischemic Injury in Clinical Trials, 2010–2016

Grupke, S. L., & Fraser, J. F. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012539-00242

The role of PPARγ in myeloid cells in experimental autoimmune encephalomyelitis

Floßdorf, J. (2013) · bonndoc (University of Bonn)

References

(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7

Stressor and cytokine interactions : implications in depressive-like pathology

Gibb, J. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-09658

Neurobiology of Neuroimmune Encephalitic Disorders

Laje, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_167-1

Neurobiology of Neuroimmune Encephalitic Disorders

Laje, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_167

Identification de programmes d'activation macrophagique et microgliale dans les formes progressives de la sclérose en plaques

Lhuillier, A. (2014) · theses.fr (ABES) · doi:10.70675/823ba73ez2984z4a8az9336zca2f18e0b69c

Développement cérébral postnatal, sommeil et activité épileptique : impact de l'invalidation de la sous-unité GluN2A des récepteurs NMDA impliquée dans le spectre des épilepsies-aphasies

Salmi, M. (2018) · theses.fr (ABES) · doi:10.70675/17f30ea1z910bz4371z8812z598bbcf6d2e8

Minocycline ameliorates CNS autoimmunity through restraint of CD4+CD11bc+ cells

Milosavljević, Z., Lazarević, M. N., Stegnjaić, G., Nikolovski, N., Mirković, K., Lodygin, D., Flügel, A., Miljković, Đ., Stanisavljević, S., & Jevtić, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823730

BindingDB Entry 50025160: Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

BindingDB (2010) · UC San Diego · doi:10.7270/q2nz87dg

Clinical trials of multiple sclerosis therapies

Cohen, J. A., & Rudick, R. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.028

Review of Novel Immunotherapeutic Strategies for MS

Wiendl, H., & Hohlfeld, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_14

The prospects of minocycline in multiple sclerosis.

Chen, X.-H., Ma, X.-M., Jiang, Y., Pi, R., Liu, Y.-Y., & Ma, L.-L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.006 · Cited by 75

Potential antibiotic treatment for multiple sclerosis?

Love, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07248-3 · Cited by 6

Minocycline ameliorates CNS autoimmunity through restraint of CD4+CD11bc+ cells

Milosavljević, Z., Lazarević, M. N., Stegnjaić, G., Nikolovski, N., Mirković, K., Lodygin, D., Flügel, A., Miljković, Đ., Stanisavljević, S., & Jevtić, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823730

Targeting leukocyte MMPs and transmigration

Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C. A., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 427

Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord

Nikodémová, M., Lee, J., Fábry, Z., & Duncan, I. D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.009 · Cited by 36